Back to search

Georgia Institute of Technology

Development of a Microneedle Patch for mRNA in Lipid Nanoparticles

Abstract

dc:description.abstract

mRNA technology offers an efficient way to develop new vaccines and therapeutics to address unmet medical needs. However, it is limited by its instability and low transfection efficiency. Lipid nanoparticles (LNPs) improve transfection and protect mRNA from enzymes in vivo but introduce more complexity and instability. Additional methods of delivery could increase the accessibility of novel mRNA technologies. In this thesis, we developed a microneedle patch (MNP) for the delivery of mRNA in LNPs. Specifically, we addressed 1) the factors of the MNP manufacturing process that influence mRNA-LNP stability and 2) the effect of LNP composition on stability in a MNP. First, we investigated elements of the MNP manufacturing process, including concentrating the mRNA-LNPs, types of excipients, excipient concentrations, pH, drying conditions, and backing cast formulations. We found that the optimal MNP design contained PVA with an epoxy backing cast, and that fabricating mRNA-LNPs at a higher initial concentration was more effective for loading into an MNP than concentrating post-fabrication. We found that pH and drying conditions had less significant effects on mRNA-LNP stability. We developed a mRNA-LNP MNP that produced in vivo expression of reporter mRNA, which was necessary for translating in vitro results to in vivo. Second, we investigated the effects of LNP composition changes on mRNA-LNP stability in MNPs, including the ionizable lipid:mRNA ratio, the lipid molar ratios, the ionizable lipid, cholesterol analogues, the phospholipid, and the PEG-linked lipid. We found that increasing the ionizable lipid content increased the stability during MNP manufacturing and that ionizable lipids that led to high in vivo expression via intradermal injection also had high expression via MNP application. We found that the ionizable lipid:mRNA ratio, cholesterol analogues, and PEG-linked lipid identity did not significantly affect mRNA-LNP MNP expression. We also discovered that in vitro characterization of mRNA-LNPs did not correlate well with in vivo expression, indicating the importance of testing new formulations in vivo. This body of work contributes to continuing efforts to develop a translatable mRNA-LNP MNP and to further the understanding of the complex nature of mRNA-LNP stability.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Biomedical Engineering (Joint GT/Emory Department)
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Sakers, Sophia Hall
Advisor dc:contributor.advisor
  • Prausnitz, Mark R.
Committee members dc:contributor.committeemember
  • Dahlman, James E
  • Dixon, Brandon
  • Cicerone, Marcus
  • Wang, Baozhong

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1853/82016

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Sakers, Sophia Hall. Development of a Microneedle Patch for mRNA in Lipid Nanoparticles. Doctoral thesis, Georgia Institute of Technology, 2025. https://hdl.handle.net/1853/82016